• AMD-070 Hydrochloride: CXCR4 Research Evidence

  2026-10-05

  This overview evaluates mavorixafor hydrochloride, also called AMD-070 hydrochloride, as a CXCR4 antagonist through the lens of the supplied evidence. It separates supplier-described mechanisms and clinical relevance from peer-reviewed findings, compares the compound’s proposed research context with independent work on ischemia and tissue injury, and outlines important limits on interpretation.

• Bazedoxifene: Evidence and Research Context

  2026-10-05

  Bazedoxifene is a selective estrogen receptor modulator established in osteoporosis treatment research and now being evaluated as a possible inhibitor of IL-6/GP130 signaling. This overview compares its estrogen-receptor and anticancer evidence, clarifies what remains preclinical, and outlines major translational limitations without providing experimental procedures.

• 3X FLAG Peptide: From Tagging to Translation

  2026-10-04

  How the 3X (DYKDDDDK) Peptide can support evidence-driven protein research, from mechanistic investigation to translational assay strategy, while keeping claims and limitations in view.

• V5 Epitope Tag Peptide: Evidence and Limits

  2026-10-03

  The V5 Epitope Tag Peptide is a defined 14-residue antigenic sequence used to support antibody-based detection of recombinant proteins. Evidence supports V5-directed antibody applications, but the commercial peptide itself does not replace genetic fusion, antibody validation, or assay-specific controls.

• Angiotensin (1-7): Applied Research Workflows

  2026-10-02

  Build reproducible cell, enzyme, and animal studies around a sequence-defined Mas receptor agonist with clear handling and assay controls. This guide connects Angiotensin (1-7) biology to ACE2 assay logic, renal fibrosis, inflammation, and translational model selection while separating literature-backed conditions from practical starting points.

• V5 Epitope Tag Peptide: Workflow Guide

  2026-10-01

  Use the V5 Epitope Tag Peptide as a defined antigen, competition control, and assay-standardization tool for recombinant protein detection. This guide connects routine Western blot and immunoprecipitation workflows with the fast-dissociating antibody strategy reported for dynamic single-molecule imaging.

• FLAG tag Peptide in Cardiovascular Assays

  2026-10-01

  The FLAG tag Peptide (DYKDDDDK) can strengthen recombinant protein detection and purification workflows for mechanistic cardiovascular research. This article connects tag design, gentle competitive elution, and assay interpretation to the ceramide–CYSLTR2/P2RY6 findings reported in Nature.

• USP36–Snail1 Control of Ribosome Stress in Cancer

  2026-09-30

  The reference study identifies a JNK–USP36–Snail1 mechanism that enables solid tumor cells to preserve nucleolar ribosome biogenesis during ribotoxic stress. Its findings explain why homoharringtonine can be effective in leukemia yet less active against solid tumors, and provide a rationale for combining ribosome inhibition with pathway-directed interventions.

• Moxidectin: From Anthelmintic to Assay Design

  2026-09-30

  Moxidectin is a macrocyclic lactone anthelmintic with established veterinary applications and emerging antifungal combination potential. This article explains how its Candida–polyene mechanism should shape assay design, controls, interpretation, and translational decisions.

• Polygodial Workflows for TRPA1 Channel Research

  2026-09-29

  Build a controlled workflow that connects rapid TRPA1-dependent calcium signals with slower epithelial inflammatory outputs. This guide positions Polygodial as a practical chemical stimulus for sensory ion channel studies while separating reference-backed findings from starting conditions that require local optimization.

• PPT: Selective ERα Agonist for Research

  2026-09-29

  PPT (Propyl Pyrazole Triol) is a selective ERα agonist used to separate estrogen receptor alpha signaling from ERβ activity. Product data report approximately 410-fold ERα-over-ERβ selectivity, cellular ERα-mediated gene-expression effects, and uterotrophic activity in immature rats.

• From FLAG Capture to Mechanistic Confidence

  2026-09-28

  The 3X (DYKDDDDK) Peptide is more than a detection reagent: it can function as a strategic control point in recombinant protein purification, assay development, and structural biology. This article connects FLAG-based workflows with mechanistic lessons from recent PSS2 research and outlines how translational teams can improve confidence without overstating what an epitope tag can prove.

• IMP and Spatial RNA Modification Profiling

  2026-09-28

  IMP and inosine-related RNA measurements are not interchangeable: chemical form matters when interpreting spatial RNA modification data. This guide explains how APEX-RNA-MS maps modified RNA near cellular structures, what its findings establish, and how to assess IMP’s role in a compatible analytical workflow.

• Moxidectin for Polyene Synergy Research

  2026-09-27

  Explore how Moxidectin can be tested as a potentiator of amphotericin B and nystatin against Candida albicans, rather than assumed to act as a stand-alone antifungal. This practical guide connects the reported ergosterol mechanism to checkerboard, biofilm, and validation workflows—with clear boundaries between published findings and suggested assay starting conditions.

• Ibrexafungerp Against Fluconazole-Resistant C. auris

  2026-09-26

  Wiederhold and colleagues tested ibrexafungerp against 54 Candida auris isolates and in a neutropenic mouse model of invasive candidiasis, finding consistent in vitro activity and improved outcomes with higher-dose treatment begun 24 hours after infection. The study supports further evaluation of an orally administered glucan-synthesis inhibitor while underscoring that these preclinical results do not establish clinical efficacy.

7881 records 1/526 page Next 12345 下5页 Last page